Mr. Chairman, I rise today to strongly object to the reduction in assistance to Colombia and the significant redirection of funding for counternarcotic programs in this legislation. Now is not the time to turn our backs on one of our most…
Mr. Chairman, I rise today to strongly object to the reduction in assistance to Colombia and the significant redirection of funding for counternarcotic programs in this legislation.
Now is not the time to turn our backs on one of our most important democratic allies in the Western Hemisphere. We need to reaffirm, not dismantle, our commitment to these programs, to the people of Colombia, and to American citizens.
The drug trade in Colombia is a major factor in the instability in Latin America; it is killing Americans every day, and is a source of funding for terrorism in the hemisphere.
I have traveled to Colombia several times over the past few years and can say firsthand our significant investment is beginning to pay dividends. Under the leadership of President Uribe, Colombia has experienced success in fighting narcoterrorism and bringing democratic stability to the country.
Now is not the time to cut funding--when progress is being made.
We must recognize the difficult work of President Uribe and the challenges he faces with guerillas, paramilitary groups, drug traffickers, and terrorists.
Despite these difficulties, Uribe has rescued his country from a near-failed-state status and has reestablished state presence in areas of the country that for decades lacked it. Drug traffickers are being captured and extradited to the U.S. for prosecution, kidnapping rates have decreased significantly, and the Colombian people finally feel safe traveling within their own country.
We are also seeing tremendous results in illegal crop eradication, and Plan Colombia's efforts have produced record reductions in coca cultivation and in the destruction of drug labs. Each week brings news of new seizures of cocaine and heroin--interdictions that are usually the result of U.S. supplied intelligence.
Of course obstacles remain, and progress may be slower than my colleagues on the other side of the aisle would like it to be.
But now is not the time to turn our backs on this battle which is so intrinsically tied to our war on terrorism and the scourge of illegal drug use. The Uribe administration is committed to this war but it needs U.S. assistance to improve mobility, intelligence, and training.
Congress must continue to provide sustained funding for Plan Colombia and Andean Counterdrug Initiative programs and approve a free trade agreement.
The administration requested $589 million for promoting development and fighting drugs in Colombia.
Full funding of programs coupled with a free trade agreement is critical to sustaining our success in Colombia, fostering development and investment, and protecting our interests in Latin America.
It's simple, Mr. Chairman, we cannot win this war on drugs and drug- supported terrorism without the proper tools and resources.
Colombia is a key ally in an increasingly anti-American region--we must do everything we can to ensure it remains a political and economic partner.